Lupus

Article	Citations
16th International Congress on Antiphospholipid Antibodies Task Force Report on Antiphospholipid Syndrome Treatment Trends	83
Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression	80
10 Years of belimumab experience: What have we learnt?	57
Adult systemic lupus erythematosus in Egypt: The nation-wide spectrum of 3661 patients and world-wide standpoint	49
Delayed diagnosis adversely affects outcome in systemic lupus erythematosus: Cross sectional analysis of the LuLa cohort	45
Anifrolumab reduces flare rates in patients with moderate to severe systemic lupus erythematosus	42
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry	29
16th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome	29
Seventy years after Hench’s Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus	29
Predictive value of the neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio, platelet-to-neutrophil ratio, and neutrophil-to-monocyte ratio in lupus nephritis	28
16th International Congress on Antiphospholipid Antibodies Task Force Report on Obstetric Antiphospholipid Syndrome	26
Systemic lupus erythematosus: The search for the ideal biomarker	25
Syk inhibitor attenuates inflammation in lupus mice from FcgRIIb deficiency but not in pristane induction: the influence of lupus pathogenesis on the therapeutic effect	25
Immune thrombocytopenia and COVID-19: Case report and review of literature	23
Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK	23
Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort	22
Impact of the COVID-19 pandemic on patients with systemic lupus erythematosus: Observations from an Indian inception cohort	22
SIGLEC1 (CD169) is a sensitive biomarker for the deterioration of the clinical course in childhood systemic lupus erythematosus	22
Proprotein convertase subtilisin kexin 9 is associated with disease activity and is implicated in immune activation in systemic lupus erythematosus	21
Mortality in patients with systemic lupus erythematosus and neuropsychiatric involvement: A retrospective analysis from a tertiary referral center in the Netherlands	21
Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: A meta-analysis	20
Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality	20
Hepatic manifestations in systemic lupus erythematosus	20
COVID-19 and antiphospholipid antibodies: A position statement and management guidance from AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION)	20
Lupus, vaccinations and COVID-19: What we know now	20

The importance of pregnancy planning in lupus pregnancies	19
Erosive arthritis in systemic lupus erythematosus: not only Rhupus	19
Cell-free DNA profiling in patients with lupus nephritis	19
Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity	18
Activation of the alternative complement pathway predicts renal outcome in patients with lupus nephritis	18
Safety and immunogenicity of the quadrivalent human papillomavirus vaccine in patients with childhood systemic lupus erythematosus: a real-world interventional multi-centre study	18
Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study	17
Rituximab – The first twenty years	17
Long-term follow-up of antiphospholipid syndrome: real-life experience from a single center	17
Interleukin 23 is elevated in the serum of patients with SLE	16
The efficacy and safety of telitacicept for the treatment of systemic lupus erythematosus: a real life observational study	16
Which patients with systemic lupus erythematosus in remission can withdraw low dose steroids? Results from a single inception cohort study	16
Physician–patient interaction and medication adherence in lupus nephritis	16
Medication adherence is influenced by resilience in patients with systemic lupus erythematosus	16
The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients	16
Albumin-to-globulin ratio (AGR) as a potential marker of predicting lupus nephritis in Chinese patients with systemic lupus erythematosus	15
Systemic lupus erythematosus in the intensive care unit: a systematic review	15
Analysis of trends and causes of death in SLE patients over a 40-years period in a cohort of patients in the United Kingdom	15
Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis	14
Low expression of estrogen receptor β in renal tubular epithelial cells may cause hyperuricemia in premenopausal patients with systemic lupus erythematosus	14
In-hospital mortality and its predictors in a cohort of SLE from Northern India	14
Clinical pharmacology considerations for the approval of belimumab for the treatment of adult patients with active lupus nephritis: A regulatory perspective	14
Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis	14
Insulin resistance and serum levels of adipokines in patients with systemic lupus erythematosus: a systematic review and meta-analysis	14
Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome	14
Evaluation of belimumab treatment in patients with systemic lupus erythematosus in a clinical practice setting: Results from a 24-month OBSErve study in Argentina	14
Genetic screening of early-onset patients with systemic lupus erythematosus by a targeted next-generation sequencing gene panel	14
Three functional variants in the NLRP3 gene are associated with susceptibility and clinical characteristics of systemic lupus erythematosus	14
Amiselimod, a sphingosine 1-phosphate receptor-1 modulator, for systemic lupus erythematosus: A multicenter, open-label exploratory study	14
The multi-targets mechanism of hydroxychloroquine in the treatment of systemic lupus erythematosus based on network pharmacology	13
Ophthalmologic manifestations in primary antiphospholipid syndrome patients: A cross-sectional analysis of a primary antiphospholipid syndrome cohort (APS-Rio) and systematic review of the literature	13
COVID-19 in systemic lupus erythematosus: A pooled analysis and systematic review of case reports and series	13
The association of lupus nephritis with adverse pregnancy outcomes among women with lupus in North America	13
Prevalence, involved domains, and predictor of cognitive dysfunction in systemic lupus erythematosus	13
EBV load is associated with cfDNA fragmentation and renal damage in SLE patients	13
A comparative study on clinical and serological characteristics between patients with rhupus and those with systemic lupus erythematosus and rheumatoid arthritis	13
Rituximab use as induction therapy for lupus nephritis: a systematic review	13
Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis	13
Safety and efficacy of telitacicept in refractory childhood-onset systemic lupus erythematosus: A self-controlled before–after trial	13
Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome	13
Patient experiences and strategies for coping with SLE: A qualitative study	13
A comparison and review of three sets of classification criteria for systemic lupus erythematosus for distinguishing systemic lupus erythematosus from pure mucocutaneous manifestations in the lupus di	13
Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials	13
A home-based exercise program during COVID-19 pandemic: Perceptions and acceptability of juvenile systemic lupus erythematosus and juvenile idiopathic arthritis adolescents.	13
Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study	13
Associations of site-specific CD4+-T-cell hypomethylation within CD40-ligand promotor and enhancer regions with disease activity of women with systemic lupus erythematosus	13
Damage index for antiphospholipid syndrome during long term follow-up: Correlation between organ damage accrual and quality of life	13
Cognitive impairment in systemic lupus erythematosus is negatively related to social role participation and quality of life: A systematic review	12
Clinical characteristics and long-term outcomes of Libman–Sacks endocarditis in patients with systemic lupus erythematosus	12
Systemic lupus erythematosus and pregnancy: A retrospective single-center study of 215 pregnancies from Portugal	12

Evaluation of subclinical retinal microvascular changes in systemic lupus erythematosus patients using optical coherence tomography angiography and its relationship with disease activity	12
Clinical features, disease activity and outcomes of Malaysian children with paediatric systemic lupus erythematosus: A cohort from a tertiary centre	12
Epstein–Barr virus, cytomegalovirus and BK polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity	12
The new 2019-EULAR/ACR classification criteria specific domains at diagnosis can predict damage accrual in 670 childhood-onset systemic lupus erythematosus patients	12
COVID-19 in patients with systemic lupus erythematosus: A systematic review	12
Identification of ferroptosis-related molecular markers in glomeruli and tubulointerstitium of lupus nephritis	12
Clinical management of Lupus patients during the COVID-19 pandemic	12
Systemic lupus erythematosus patients have a distinct structural and functional skin microbiota compared with controls	12
Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study	11
Prevalence and risk factors of herpes zoster infection in patients with biopsy proven lupus nephritis undergoing immunosuppressive therapies	11
Severe pneumonia in Chinese patients with systemic lupus erythematosus	11
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome	11
Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controls	11
Identifying co-morbid fibromyalgia in patients with systemic lupus erythematosus using the Multi-Dimensional Health Assessment Questionnaire	11
Ofatumumab use in juvenile systemic lupus erythematosus: A single centre experience	11
Bioinformatic analysis of key biomarkers and immune filtration of skin biopsy in discoid lupus erythematosus	11
Outcome of clinical and subclinical myocardial injury in systemic lupus erythematosus – A prospective cohort study	11
Lupus nephritis in a transgender woman on cross-sex hormone therapy: a case for the role of oestrogen in systemic lupus erythematosus	11
Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders	11
Myositis in systemic lupus erythematosus	11
Low disease activity state in juvenile-onset systemic lupus erythematosus	11
Maternal and fetal outcomes of lupus pregnancies: A collective effort by Karnataka Rheumatologists	10
Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine	10
Combined aerobic and resistance training improves physical and executive functions in women with systemic lupus erythematosus	10
Soluble ST2 and CXCL-10 may serve as biomarkers of subclinical diastolic dysfunction in SLE and correlate with disease activity and damage	10
Impact of the first wave of the COVID-19 pandemic on systemic lupus erythematosus patients: Results from a multi-center prospective cohort	10
Effects of web-based education and counselling for patients with systemic lupus erythematosus: self-efficacy, fatigue and assessment of care	10
Hematological involvement in pediatric systemic lupus erythematosus: A multi-center study	10
Targets of Tripterygium glycosides in systemic lupus erythematosus treatment: A network-pharmacology study	9
Serum uric acid as a predictor for nephritis in Egyptian patients with systemic lupus erythematosus	9
Cutaneous, systemic features and laboratory characteristics of late- versus adult-onset systemic lupus erythematosus in 1006 Thai patients	9
Risk factors for early severe preeclampsia in obstetric antiphospholipid syndrome with conventional treatment. The impact of hydroxychloroquine	9
Something new about prognostic factors for lupus nephritis? A systematic review	9
A trial of antithrombotic therapy in patients with refractory migraine and antiphospholipid antibodies: A retrospective study of 75 patients	9
Cytokines, 25-OH vit D and disease activity in patients with juvenile-onset systemic lupus erythematosus	9
Incidence and prevalence of systemic lupus erythematosus among Korean women in childbearing years: A nationwide population-based study	9
Pediatric systemic lupus erythematosus with lupus anticoagulant hypoprothrombinemia syndrome—A case series with review of literature	9
Hydroxychloroquine blood levels predicts flare in childhood-onset lupus nephritis	9
Exploration of machine learning methods to predict systemic lupus erythematosus hospitalizations	9
New-onset lupus nephritis associated with COVID-19 infection	9
What is the value of repeat kidney biopsies in patients with lupus nephritis?	9
Antiphospholipid syndrome–mediated acute cerebrovascular diseases and long-term outcomes	9
The association between lupus serology and disease outcomes: A systematic literature review to inform the treat-to-target approach in systemic lupus erythematosus	9
An evaluation of costs associated with overall organ damage in patients with systemic lupus erythematosus in the United States	9
Risk of osteonecrosis in systemic lupus erythematosus: An 11-year Chinese single-center cohort study	9
Prevalence of subclinical synovitis of the hand in patients with systemic lupus erythematosus	9
Effect of indole-3-carbinol on transcriptional profiling of wound-healing genes in macrophages of systemic lupus erythematosus patients: an RNA sequencing assay	9
Dual trajectories of fatigue and disease activity in an inception cohort of adults with systemic lupus erythematosus over 10 years	9
Unsupervised clustering analysis of data from an online community to identify lupus patient profiles with regards to treatment preferences	8
IFNβ signaling inhibits osteogenesis in human SLE bone marrow	8
Proton magnetic resonance spectroscopy (1H-MRS) in rheumatic autoimmune diseases: A systematic review	8
Associations between daily alcohol consumption and systemic lupus erythematosus-related cytokines and chemokines among US female nurses without SLE	8
Low C4 as a risk factor for severe neuropsychiatric flare in patients with systemic lupus erythematosus	8
Altered redox regulation by Nrf2-Keap1 system in dendritic cells of systemic lupus erythematosus patients	8
Prevalence and treatment conditions for hypertension and dyslipidaemia complicated with systemic lupus erythematosus: A multi-centre cross-sectional study	8
The combined role of clinical, reflectance confocal microscopy and dermoscopy applied to chronic discoid cutaneous lupus and subacutus lupus erythematosus: A case series and literature review	8
Risk of adverse pregnancy outcomes in Japanese systemic lupus erythematosus patients with prior severe organ manifestations: A single-center retrospective analysis	8
Dyslipidemia is insufficiently treated in antiphospholipid syndrome patients	8
Rituximab use in pediatric systemic lupus erythematosus: Indications, efficacy and safety in an Indian cohort	8
Association between periodontitis and systemic lupus erythematosus: a meta-analysis	8
Immunosuppressive therapy of systemic lupus erythematosus associated peripheral neuropathy: A systematic review	8
Lupus aortitis: A fatal, inflammatory cardiovascular complication in systemic lupus erythematosus	8
Twenty-year trends in all-cause mortality of patients with systemic lupus erythematosus in Mexico: Results from a nationwide health registry	8
Association of MALAT-1 gene single nucleotide polymorphisms with genetic susceptibility to systemic lupus erythematosus	8
Ambulatory blood pressure in patients with systemic lupus erythematosus: Association with markers of immune activation	8
Altered oxidative stress markers in relation to T cells, NK cells & killer immunoglobulin receptors that are associated with disease activity in SLE patients	8
The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: A retrospective single-center study	8
Discovering the signature of a lupus-related microRNA profile in the Gene Expression Omnibus repository	8
Effect of early eradication therapy on systemic lupus erythematosus risk in patients with Helicobacter pylori infection: a nationwide population-based cohort study	8
Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus	8
Venous thrombosis in a systemic lupus erythematosus patient with antiphospholipid antibodies coinciding with mild Covid-19	8
Use of telemedicine for follow-up of lupus nephritis in the COVID-19 outbreak: The 6-month results of a randomized controlled trial	8
The landscape of systemic lupus erythematosus in Brazil: An expert panel review and recommendations	8
Role of micro-RNA132 and its long non coding SOX2 in diagnosis of lupus nephritis	8
Lower socioeconomic status worsens outcome of patients with systemic lupus erythematosus independently of access to healthcare	8
Health care practitioners’ confidence assessing lupus-related rashes in patients of color	8
Cut off point of neutrophil-to-lymphocyte ratio as a marker of active disease in systemic lupus erythematosus	8
Social media as source of information for Spanish-speaking patients with systemic lupus erythematosus	7
Multimorbidity among incident Finnish systemic lupus erythematosus patients during 2000–2017	7
Low health numeracy is associated with higher disease activity in systemic lupus erythematosus	7

Pregnancy in patients with systemic lupus erythematosus after cyclophosphamide therapy	7
Nailfold capillaroscopy findings in cutaneous lupus erythematosus patients with or without digital lesions and comparison with dermatomyositis patients: A prospective study	7
Methyl donor micronutrients, CD40-ligand methylation and disease activity in systemic lupus erythematosus: A cross-sectional association study	7
Systemic lupus erythematosus and COVID-19 during pregnancy	7
Cotrimoxazole prophylaxis prevents major infective episodes in patients with systemic lupus erythematosus on immunosuppressants: A non-concurrent cohort study	7
Systemic erythematosus lupus and pregnancy outcomes in a Colombian cohort	7
Distribution of IgG subclass anti-nuclear antibodies (ANAs) in systemic lupus erythematosus	7
Plant-based dietary changes may improve symptoms in patients with systemic lupus erythematosus	7
Oral manifestations associated with antimalarial therapy in patients with systemic lupus erythematosus	7
Autoimmune thyroid diseases, autoimmune hepatitis, celiac disease and type 1 diabetes mellitus in pediatric systemic lupus erythematosus: Results from the CARRA Legacy Registry	7
Role of interleukin-6 and interferon-α in systemic lupus erythematosus: A case–control study and meta-analysis	7
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab	7
Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis	7
Hospitalization in patients with systemic lupus erythematosus at Tawam Hospital, United Arab Emirates (UAE): Rates, causes, and factors associated with length of stay	7
Joint involvement influences quality of life in systemic lupus erythematosus patients	7
The potential use of serum interleukin-21 as biomarker for lupus nephritis activity compared to cytokines of the tumor necrosis factor (TNF) family	7
Prevalence and incidence of systemic lupus erythematosus in Tucumán, Argentina	7
Clinical characterization, outcomes, and prognosis in patients with systemic lupus erythematosus admitted to the intensive care unit	7
Comprehensive bioinformatics analysis of mRNA expression profiles and identification of a miRNA–mRNA network associated with lupus nephritis	7
Detection of putative autoantibodies in systemic lupus erythematous using a novel native-conformation protein microarray platform	7
Lupus nephritis: correlation of immunohistochemical expression of C4d, CD163-positive M2c-like macrophages and Foxp3-expressing regulatory T cells with disease activity and chronicity	7
Aggravation of discoid lupus erythematosus in a patient with psoriasis and psoriatic arthritis during treatment of secukinumab: A case report and review of literature	7
Factors associated with quality of life in cutaneous lupus erythematosus using the Revised Wilson and Cleary Model	7
Laboratory-confirmed pediatric COVID-19 in patients with rheumatic diseases: A case series in a tertiary hospital	7
Immunoglobulin levels in systemic lupus erythematosus: A narrative review	7
CD14 (C-159T) polymorphism is associated with increased susceptibility to SLE, and plasma levels of soluble CD14 is a novel biomarker of disease activity: A hospital-based case-control study	7
Clinical characteristics of itch in cutaneous lupus erythematosus: A prospective, multicenter, multinational, cross-sectional study	7
Description of damage in different clusters of patients with antiphospholipid syndrome	7
Identifying additional risk factors for arterial and venous thrombosis among pediatric antiphospholipid antibodies carriers	7
Age differences in secular trends in black–white disparities in mortality from systemic lupus erythematosus among women in the United States from 1988 to 2017	7
Systemic lupus erythematosus children in Egypt: Homeland spectrum amid the global situation	7
Uncoupled bone remodeling is characteristic of bone damage in premenopausal women with new-onset systemic lupus erythematosus	7
Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab	7
Association of PER2 gene single nucleotide polymorphisms with genetic susceptibility to systemic lupus erythematosus	7
The cost of flares among patients with systemic lupus erythematosus with and without lupus nephritis in the United States	6
Treatment with low-dose prednisone in refractory obstetric antiphospholipid syndrome: A retrospective cohort study and meta-analysis	6
Identification and analysis of the predictive urinary exosomal miR-195-5p in lupus nephritis based on renal miRNA-mRNA co-expression network	6
Brain network reorganisation and spatial lesion distribution in systemic lupus erythematosus	6
Elevated apoptosis and abnormal apoptosis signaling of regulatory T cells in patients with systemic lupus erythematosus	6
Association of microRNA-125a with the clinical features, disease activity and inflammatory cytokines of juvenile-onset lupus patients	6
Cognitive dysfunction among people with systemic lupus erythematosus is associated with reduced participation in daily life	6
Applying SLICC and ACR/EULAR systemic lupus erythematosus classification criteria in a cohort of patients with undifferentiated connective tissue disease	6
Bullous lupus as the first manifestation of systemic lupus erythematosus in the pediatric population: A diagnostic challenge in daily practice	6
White matter microstructure alterations in systemic lupus erythematosus: A preliminary coordinate-based meta-analysis of diffusion tensor imaging studies	6
Comorbidities of systemic lupus erythematosus prior to and following diagnosis in different age-at-onset groups	6
Severe pulmonary arterial hypertension and interstitial pneumonia related to systemic lupus erythematosus successfully treated with mycophenolate mofetil: A novel case report	6
Jaccoud-type lupus arthropathy	6
Correlation between irreversible organ damage and the quality of life of patients with systemic lupus erythematosus: The Kyoto Lupus Cohort survey	6
Bronchiolitis obliterans organizing pneumonia as the pulmonary manifestation of lupus: A review of three cases	6
Systemic lupus erythematosus in children and adults: A retrospective study in Brazilian patients	6
The effect of smoking on cumulative damage in systemic lupus erythematosus: An incident cohort study	6
The use of patient-reported outcome measures to classify type 1 and 2 systemic lupus erythematosus activity	6
MOG-IgG-associated disorder and systemic lupus erythematosus disease: Systematic review	6
Mental health in patients with rheumatic diseases related to COVID-19 pandemic: Experience in a tertiary care center in Latin America	6
Prednisone and long-term damage in systemic lupus erythematosus: Which is the threshold dose? A pilot study	6
Differences in quality of life in patients with cutaneous lupus erythematosus with varying income levels	6
Population pharmacokinetics of mycophenolic acid in Mexican patients with lupus nephritis	6
Systemic lupus erythematosus and risk of sexual dysfunction: A systematic review and Meta-Analysis	6
Epidemiology of disease-activity related ophthalmological manifestations in Systemic Lupus Erythematosus: A systematic review	6
Vitamin D in Colombian patients with systemic lupus erythematosus and its correlation with disease activity	6
2019 ACR/EULAR classification criteria and therapy in predicting organ damage accrual in patients with childhood-onset systemic lupus erythematosus: A retrospective study over the last 29 years	6
Health-related quality of life, fatigue and health utilities in lupus nephritis: A systematic literature review	6
Safety of tacrolimus use during pregnancy and related pregnancy outcomes in patients with systemic lupus erythematosus: A retrospective single-center analysis in Japan	6
Antiphospholipid antibodies and idiopathic infertility	6
Associations with thrombosis are stronger for antiphosphatidylserine/prothrombin antibodies than for the Sydney criteria antiphospholipid antibody tests in SLE	6
Characteristics of lupus nephritis in Saudi lupus patients: A retrospective observational study	6
Association of MBL-2 gene polymorphisms with systemic lupus erythematosus: an updated meta-analysis and trial sequential analysis	6
Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review	6
CD40 and CD72 expression and prognostic values among children with systemic lupus erythematosus: a case–control study	6
The presence of lupus nephritis additionally increases the risk of preeclampsia among pregnant women with systemic lupus erythematosus	6
Sandplay therapy could be a method to decrease disease activity and psychological stress in children with systemic lupus erythematosus	6
Juvenile lupus and serum vitamin D levels: A cross-sectional study	5
Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications	5
Induced abortions in women with systemic lupus erythematosus	5
Dilemma of belimumab therapy (dis)continuation during pregnancy: Results of a retrospective study in eudravigilance	5
Association between alcohol intake and the risk of systemic lupus erythematosus: A systematic review and meta-analysis	5
The changes in bone turnover markers of female systemic lupus erythematousus patients without glucocorticoid	5
Why lupus patients discontinue antimalarials in real life: A 50 years-experience from a reference centre	5
Characterization of autoantibodies and cytokines related to cutaneous lupus erythematosus	5
Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure	5
Validation and verification of the Japanese version of the systemic lupus erythematosus symptom checklist for patient quality of life	5
Childhood Systemic Lupus Erythematosus: Presentation, management and long-term outcomes in an Australian cohort	5
Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review	5
Cosmetic camouflage improves health-related quality of life in women with systemic lupus erythematosus and permanent skin damage: A controlled intervention study	5
Aseptic meningitis as initial manifestation of systemic lupus erythematosus: Case series	5
Intrarenal injection of mesenchymal stem cell for treatment of lupus nephritis in mice – a pilot study	5
Validation of the adjusted global antiphospholipid syndrome score in systemic lupus erythematosus patients in Argentina	5
Hematologic manifestations of juvenile systemic lupus erythematosus: An emphasis on anemia	5
Avoiding misclassification of thrombotic primary antiphospholipid syndrome as systemic lupus erythematosus (SLE): What are the best-performing SLE classification criteria?	5
A prospective study of reproductive factors in relation to risk of systemic lupus erythematosus among black women	5
Belimumab in subacute cutaneous lupus erythematosus	5
Anti-recoverin antibodies indicate fundus abnormalities in systemic lupus erythematosus	5
Frequency of Porphyromonas gingivalis and fimA genotypes in patients with periodontitis and systemic lupus erythematosus	5
Metabolic syndrome predicts new damage in systemic lupus erythematosus patients: Data from the Almenara Lupus Cohort	5
Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer	5